Steba Biotech S.A.
13 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study (NCT04620239) | Steba Biotech S.A. | 2021-03-22 |
| Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer (NCT04225299) | Steba Biotech S.A. | 2020-03-31 |
| Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer (NCT03849365) | Steba Biotech S.A. | 2019-01-21 |
| Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer. (NCT03315754) | Steba Biotech S.A. | 2017-10-02 |
Track Steba Biotech S.A. automatically
Every clearance here is in the API, with alerts when new ones post.